Search results for: 'deaf+teva+and+benchmarking'
- Did you mean
- deal term and benchmarking
-
Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00
Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Regenerative Medicine Collaboration and Licensing Deals 2019-2025May 2025$3,995.00
Regenerative Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Global Academic and Non-Profit Partnering Terms and Agreements 2019-2025May 2025$4,995.00
Global Academic and Non-Profit Partnering Terms and Agreements 2019-2025 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals.
Learn More -
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025March 2025$3,995.00
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More -
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2025April 2025$3,995.00
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2025
Learn More -
Dermatology Collaboration and Licensing Deals 2016-2025April 2025$3,995.00
Dermatology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025May 2025$3,995.00
Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Antibiotic Collaboration and Licensing Deals 2016-2025May 2025$3,995.00
Antibiotic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Autoimmune Collaboration and Licensing Deals 2016-2025April 2025$3,995.00
Autoimmune Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Antibody Collaboration and Licensing Deals 2019-2025May 2025$3,995.00
Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More